Accenture plc
175.80USD
-3.2300 (-1.80%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $3.18▼ | $3.28 | 0 | 1 |
| Next quarter | $3.99▼ | $4.05 | 0 | 1 |
| Current year | $13.86▼ | $13.87 | 0 | 3 |
| Next year | $14.66▼ | $14.88 | 1 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-05-31 | $3.71 | $3.8 | +0.09 (+2.5%) |
| 2026-02-28 | $2.84 | $2.93 | +0.09 (+3.3%) |
| 2025-11-30 | $3.72 | $3.94 | +0.22 (+5.9%) |
| 2025-08-31 | $2.97 | $3.03 | +0.06 (+2.0%) |
579 ratings from 46 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $151 $173 | Aug 26, 2026 |
| Wolfe Research | Maintained | Outperform | $165 $215 | Aug 25, 2026 |
| Citigroup | Maintained | Neutral | $135 $190 | Aug 24, 2026 |
| Wells Fargo | Maintained | Overweight | $200 $194 | Jul 20, 2026 |
| TD Cowen | Maintained | Hold | $150 $151 | Jun 26, 2026 |
| Mizuho | Maintained | Outperform | $280 $226 | Jun 23, 2026 |
| Truist Securities | Maintained | Hold | $210 $150 | Jun 22, 2026 |
| TD Cowen | Downgraded from Buy | Hold | $258 $150 | Jun 22, 2026 |
| Susquehanna | Maintained | Neutral | $186 $140 | Jun 22, 2026 |
| RBC Capital | Maintained | Outperform | $253 $175 | Jun 22, 2026 |
| Guggenheim | Maintained | Buy | $225 $185 | Jun 22, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $177 $130 | Jun 22, 2026 |
| Evercore ISI Group | Maintained | Outperform | $250 $180 | Jun 18, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $240 $177 | Jun 15, 2026 |
| JP Morgan | Maintained | Overweight | $247 $201 | Jun 8, 2026 |
| TD Cowen | Maintained | Buy | $282 $258 | Jun 8, 2026 |
| Wells Fargo | Maintained | Overweight | $275 $248 | Jun 4, 2026 |
| Goldman Sachs | Maintained | Buy | $300 $270 | Jun 3, 2026 |
| Stifel | Maintained | Buy | $315 $270 | Jun 3, 2026 |
| Citigroup | Maintained | Neutral | $215 $195 | Jun 1, 2026 |
| Truist Securities | Downgraded from Buy | Hold | $260 $210 | Jun 1, 2026 |
| Mizuho | Maintained | Outperform | $309 $280 | Mar 23, 2026 |
| JP Morgan | Maintained | Overweight | $243 $247 | Mar 20, 2026 |
| BMO Capital | Maintained | Market Perform | $300 $230 | Mar 20, 2026 |
| RBC Capital | Maintained | Outperform | $295 $253 | Mar 20, 2026 |
160 filings from 28 insiders · 78 buy / 3 sell over 6m
Officers and directors of ACN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Clifford Katherine LeeOfficer, Chief Leadership & HR Officer | Grant | 92 | $189.09 | $17k | Sep 5, 2026 |
| Hogan Catherine KiernanOfficer, Chief Operating Officer | Grant | 113 | $189.09 | $21k | Sep 5, 2026 |
| Park Angie YOfficer, Chief Financial Officer | Grant | 145 | $189.09 | $27k | Sep 5, 2026 |
| Sharma ManishOfficer, Chief Strategy & Services Ofcr | Grant | 97 | $189.09 | $18k | Sep 5, 2026 |
| Walsh John FOfficer, CEO-The Americas | Grant | 146 | $189.09 | $28k | Sep 5, 2026 |
| Unruch JoelOfficer, General Counsel/Corp Secretary | Grant | 145 | $189.09 | $27k | Sep 5, 2026 |
| Sweet Julie SpellmanDirector; Officer, Chair and CEO | Grant | 205 | $189.09 | $39k | Sep 5, 2026 |
| Burgum Melissa AOfficer, Chief Accounting Officer | Grant | 106 | $189.09 | $20k | Sep 5, 2026 |
| PARK ANGIE YChief Financial Officer | Grant | 23 | — | — | Aug 14, 2026 |
| JOPE ALAN C.Director | Grant | 14 | — | — | Aug 14, 2026 |
| BRUDERMUELLER MARTINDirector | Grant | 9 | — | — | Aug 14, 2026 |
| SHARMA MANISHOfficer | Grant | 17 | — | — | Aug 14, 2026 |
| NASON JENNIFERDirector | Grant | 9 | — | — | Aug 14, 2026 |
| UOTANI MASAHIKODirector | Grant | 9 | — | — | Aug 14, 2026 |
| CLIFFORD KATHERINE LEEOfficer | Grant | 50 | — | — | Aug 14, 2026 |
| HOGAN CATHERINE KIERNANChief Operating Officer | Grant | 50 | — | — | Aug 14, 2026 |
| UNRUCH JOEL SCOTTGeneral Counsel | Grant | 88 | — | — | Aug 14, 2026 |
| PRICE PAULA ADirector | Grant | 14 | — | — | Aug 14, 2026 |
| WALSH JOHN FOfficer | Grant | 24 | — | — | Aug 14, 2026 |
| RENDUCHINTALA VENKATA S MDirector | Grant | 9 | — | — | Aug 14, 2026 |
No analyst notes on ACN yet.
Analyst Ratings
25 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 11 | 13 | 0 | 0 | Buy2.37 |
| 1 mo ago | 3 | 11 | 13 | 0 | 0 | Buy2.37 |
| 2 mo ago | 2 | 12 | 13 | 0 | 0 | Buy2.41 |